-
-
-
-
-
-
-
Mineralys presents positive chronic kidney disease data for lorundrostat
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS), Optimistic on lorundrostat
-
-
-
15,671 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

